Gheyas F[au] - Search Results

Year	Number of Results
2000	2
2001	1
2002	3
2003	2
2004	2
2005	1
2006	1
2008	1
2009	1
2015	1
2016	2
2017	2
2018	3
2019	1
2021	4
2022	1

1

Leveraging model-informed approaches for drug discovery and development in the cardiovascular space.

Dockendorf MF, Vargo RC, Gheyas F, Chain ASY, Chatterjee MS, Wenning LA. Dockendorf MF, et al. Among authors: gheyas f. J Pharmacokinet Pharmacodyn. 2018 Jun;45(3):355-364. doi: 10.1007/s10928-018-9571-3. Epub 2018 Jan 20. J Pharmacokinet Pharmacodyn. 2018. PMID: 29353335 Free PMC article. Review.

2

A method to estimate probability of disease and vaccine efficacy from clinical trial immunogenicity data.

Dudášová J, Laube R, Valiathan C, Wiener MC, Gheyas F, Fišer P, Ivanauskaite J, Liu F, Sachs JR. Dudášová J, et al. Among authors: gheyas f. NPJ Vaccines. 2021 Nov 4;6(1):133. doi: 10.1038/s41541-021-00377-6. NPJ Vaccines. 2021. PMID: 34737322 Free PMC article.

3

Operating characteristics of stepwise covariate selection in pharmacometric modeling.

Ahamadi M, Largajolli A, Diderichsen PM, de Greef R, Kerbusch T, Witjes H, Chawla A, Davis CB, Gheyas F. Ahamadi M, et al. Among authors: gheyas f. J Pharmacokinet Pharmacodyn. 2019 Jun;46(3):273-285. doi: 10.1007/s10928-019-09635-6. Epub 2019 Apr 24. J Pharmacokinet Pharmacodyn. 2019. PMID: 31020450

4

Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group.

Bromley CM, Close S, Cohen N, Favis R, Fijal B, Gheyas F, Liu W, Lopez-Correa C, Prokop A, Singer JB, Snapir A, Tchelet A, Wang D, Goldstaub D; Industry Pharmacogenomics Working Group. Bromley CM, et al. Among authors: gheyas f. Pharmacogenomics J. 2009 Feb;9(1):14-22. doi: 10.1038/tpj.2008.11. Epub 2008 Sep 16. Pharmacogenomics J. 2009. PMID: 18794908 Review.

5

A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 Mutation.

Ahamadi M, Mehrotra N, Hanan N, Lai Yee K, Gheyas F, Anton J, Bani M, Boroojerdi B, Smit H, Weidemann J, Macha S, Thuillier V, Chen C, Yang M, Williams-Gray CH, Stebbins GT, Pagano G, Hang Y, Marek K, Venuto CS, Javidnia M, Dexter D, Pedata A, Stafford B, Akalu M, Stephenson D, Romero K, Sinha V; Critical Path for Parkinson’s Consortium. Ahamadi M, et al. Among authors: gheyas f. Clin Pharmacol Ther. 2021 Aug;110(2):508-518. doi: 10.1002/cpt.2277. Epub 2021 Jun 12. Clin Pharmacol Ther. 2021. PMID: 33894056

6

Pharmacokinetics, Safety and Tolerability of Anacetrapib, a Novel Cholesteryl Ester Transfer Protein (CETP) Inhibitor, After Single and Multiple Doses in Healthy Chinese Subjects.

Chen H, Chen W, Li H, Xu H, Yuan F, Sheng L, Liu C, Lin P, Yang M, Li X, Liu Y, Walker BM, Gheyas F, Iwamoto M, Stoch SA, Krishna R. Chen H, et al. Among authors: gheyas f. Adv Ther. 2021 Jul;38(7):3973-3985. doi: 10.1007/s12325-021-01794-8. Epub 2021 Jun 8. Adv Ther. 2021. PMID: 34101144

7

Pharmacokinetics and Pharmacodynamics of Anacetrapib in Black and White Healthy Subjects.

Krishna R, Gheyas F, Corr C, Cote J, Liu Y, Wagner J, Gutstein DE. Krishna R, et al. Among authors: gheyas f. J Clin Pharmacol. 2018 Dec;58(12):1578-1585. doi: 10.1002/jcph.1287. Epub 2018 Jul 20. J Clin Pharmacol. 2018. PMID: 30029292

8

Chronic Administration of Anacetrapib Is Associated With Accumulation in Adipose and Slow Elimination.

Krishna R, Gheyas F, Liu Y, Hagen DR, Walker B, Chawla A, Cote J, Blaustein RO, Gutstein DE. Krishna R, et al. Among authors: gheyas f. Clin Pharmacol Ther. 2017 Nov;102(5):832-840. doi: 10.1002/cpt.700. Epub 2017 May 2. Clin Pharmacol Ther. 2017. PMID: 28380664 Clinical Trial.

9

Pharmacokinetics and Pharmacodynamics of Anacetrapib Following Single Doses in Healthy, Young Japanese and White Male Subjects.

Krishna R, Gheyas F, Liu Y, Cote J, Laterza O, Ruckle JL, Wagner JA, Denker AE. Krishna R, et al. Among authors: gheyas f. J Clin Pharmacol. 2018 Feb;58(2):254-262. doi: 10.1002/jcph.1004. Epub 2017 Sep 8. J Clin Pharmacol. 2018. PMID: 28884824 Clinical Trial.

10

Population pharmacokinetic/pharmacodynamic assessment of imipenem/cilastatin/relebactam in patients with hospital-acquired/ventilator-associated bacterial pneumonia.

Patel M, Bellanti F, Daryani NM, Noormohamed N, Hilbert DW, Young K, Kulkarni P, Copalu W, Gheyas F, Rizk ML. Patel M, et al. Among authors: gheyas f. Clin Transl Sci. 2022 Feb;15(2):396-408. doi: 10.1111/cts.13158. Epub 2021 Oct 27. Clin Transl Sci. 2022. PMID: 34704389 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results